ArticlePloS one2019

Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India.

Yashika Chugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.